Cellectar Biosciences, Inc. — Director's Dealing 2014

Aug 18, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2014-08-14

Reporting Person: Genn John Patrick (VP of Business Development)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.00001 per share	3532	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$7.40	2023-12-13	Common Stock (6250)		Direct
Employee Stock Option (right to buy)	$15.00	2022-12-14	Common Stock (7500)		Direct
Employee Stock Option (right to buy)	$9.00	2021-12-16	Common Stock (3750)		Direct
Employee Stock Option (right to buy)	$28.00	2021-05-18	Common Stock (7500)		Direct
Stock Purchase Warrant (right to buy)	$12.00	2016-12-06	Common Stock (2083)		Direct

Footnotes

F1: Option vests in equal quarterly increments over a period of three years from the date of grant. Option expires on the tenth anniversary of the date of grant.